Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.07. | Cano Health has emerged from bankruptcy, company says | 2 | FierceHealthcare | ||
01.07. | Cano Health, Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
28.06. | Cano Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
17.06. | Cano Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
CANO HEALTH Aktie jetzt für 0€ handeln | |||||
04.06. | Cano Health, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
21.05. | Cano Health, Inc.: Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan | 107 | PR Newswire | Emergence from Chapter 11 Expected in Third Quarter of 2024
MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care... ► Artikel lesen | |
05.02. | NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings | 383 | PR Newswire | MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the... ► Artikel lesen | |
05.02. | Cano Health, Inc.: Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position | 328 | PR Newswire | Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow
Receives Commitment for $150 Million in New Capital... ► Artikel lesen | |
29.12.23 | Cano Health, Inc.: Cano Health Receives NYSE Notice of Non-Compliance with Market Capitalization Criteria | 1.183 | PR Newswire | Accelerates Transformation Plan, Now Targeting $290 million of Cost Reductions
MIAMI, Dec. 29, 2023 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 54,80 | -3,69 % | Carl Zeiss Meditec Aktie: Planänderungen erforderlich | Die Carl Zeiss Meditec-Aktie verzeichnete am Handelstag einen deutlichen Kursrückgang. Im XETRA-Handel fiel der Aktienkurs um 2,3 Prozent auf 56,65 Euro, nachdem er bei Börseneröffnung noch bei 58,65... ► Artikel lesen | |
MEDTRONIC | 80,95 | +1,45 % | Ihre wichtigsten Termine: Heute im Fokus: Walmart, Qualcomm, Medtronic, Nestle, Thyssenkrupp und Sto | © Foto: Charles Krupa/AP/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00... ► Artikel lesen | |
INTUITIVE SURGICAL | 524,20 | +1,96 % | Unglaubliche Prognose für Montag setzt Intuitive Surgical Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
STRATEC | 27,650 | -1,07 % | Kurs von Stratec bricht ein (28,80 €) | Zu den großen Verlierern an der Börse zählt heute der Anteilsschein von Stratec . Der Titel verliert deutlich an Wert. Ein Minus von 6,65 Prozent zeigt die Kurstafel für das Wertpapier von Stratec an.... ► Artikel lesen | |
ROKU | 65,80 | +0,97 % | Smart Money Is Betting Big In ROKU Options | ||
EUROFINS SCIENTIFIC | 46,430 | +0,80 % | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2024 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal... ► Artikel lesen | |
M1 KLINIKEN | 16,200 | -5,81 % | EQS-News: M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele | EQS-News: M1 Kliniken AG
/ Schlagwort(e): Quartalsergebnis/9-Monatszahlen
M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 1,158 | +2,12 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium | SEATTLE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical stage biopharmaceutical company developing innovative medicines in areas... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
ZIMMER BIOMET | 103,15 | -0,53 % | Is Wall Street Bullish or Bearish on Zimmer Biomet Stock? | ||
RYMAN HEALTHCARE | 2,720 | +2,95 % | RYMAN HEALTHCARE LIMITED: SPH Notice - Forsyth Barr Investment Management Limited | ||
QUIDELORTHO | 35,200 | -1,12 % | Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted | ||
TEMPEST THERAPEUTICS | 0,839 | -1,18 % | TPST Stock Plummets to 52-Week Low at $0.85 Amid Market Struggles | ||
AMBU | 15,025 | 0,00 % | NASDAQ OMX Nordic: Stressed market conditions in derivatives on AMBU (304/24) | Nasdaq has decided to call for stressed market conditions in derivatives on
Ambu AS (AMBU) for four hours, after which time an assessment of market
conditions will be made to determine if stressed market... ► Artikel lesen | |
VERU | 0,586 | -1,76 % | Veru Inc.: Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results | --Phase 2b QUALITY study of enobosarm in combination with semaglutide (Wegovy®*) exceeds targeted full enrollment of >150 patients-- --Topline data for primary endpoint of lean body mass expected... ► Artikel lesen |